Trial intelligence / Profile preview

Clonidine effects on visuospatial attention bias

NL-OMON35172Active, not recruiting

Sponsor
Utrecht University
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Trial of clonidine (2 arms), sponsored by Utrecht University. Primary endpoints: Validity effect in visuospatial cueing paradigm, Stop signal reaction time and 6 more. Started Mar 2010; status: active, not recruiting.

02

Drugs

clonidine

Beyond the preview

Go deeper on NL-OMON35172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call